

HY-P991641 · 1 mg
MedChemExpress · Cat: HY-P991641
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/imc-eb10.html
Description
IMC-EB10 LY3012218 is an anti-FLT3 monoclonal antibody. IMC-EB10 binds to FLT3 with high affinity Kd = 158 pM and blocks the binding of FLT3 ligand to FLT3 IC50 ? 10 nM , thereby inhibiting MAPK, STAT5, and PI3K/Akt signaling in leukemia cells. IMC-EB10 can enhance the anti-leukemic effect of Methotrexate HY-14519 and inhibit leukemias expressing wild-type or ITD-mutated FLT3 receptors. IMC-EB10 prolongs the survival of acute lymphoblastic leukemia ALL cells and primary leukemia samples and reduces engraftment in non-obese diabetic/severe combined immunodeficiency patients. IMC-EB10 is indicated for leukemia research.







